Navigation Links
FASEB announces 2014 SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
Date:1/22/2014

Bethesda, MD This 2014 FASEB Science Research Conference focuses on recent advances in our understanding of the neuroimmune axis and its role in disease processes. The importance of the neuroimmune axis in disease pathophysiology and therapies will be discussed for benchmark nervous system disorders, such as multiple sclerosis and spinal cord injury.

In addition, emerging areas where the importance of the neuroimmune axis has only recently been recognized, such as neuropsychiatric disorders, lysosomal storage diseases and axonal regeneration will be discussed. This FASEB Conference brings together physician-scientists and basic scientists as well as postdoctoral and graduate trainees for presentations and one-on-one discussions to broaden our understanding of fundamental aspects of disease mechanisms and therapeutic strategies in a highly collaborative and collegial environment.

A new training component associated with this conference will include a one day pre-meeting course on neuroimmunology, with material crafted to coincide with the major scientific topics covered during the main meeting. The interdisciplinary nature of this conference arises from an understanding that neuroimmune processes are intimately linked to the pathophysiology of numerous nervous system disorders, and through understanding the cellular and molecular mechanisms of these pathologies, more effective therapies may be realized. The conference is attended by immunologists, neuroscientists, neuroimmunologists, physicians and physician-scientists and is the only long-standing specialized conference held in North America to regularly attract members from each of these related, but distinct disciplines.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces 2014 Science Research Conference: Nutrient Sensing and Metabolic Signaling
2. FASEB announces 2014 Science Research Conference: Retinal Neurobiology and Visual Processing
3. FASEB announces 2014 Science Research Conference: Virus Structure and Assembly
4. FASEB announces 2014 Science Research Conference: Protein Folding in the Cell
5. FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
6. FASEB announces SRC: Molecular Mechanisms of Intestinal Lipid Transport & Metabolism
7. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
8. FASEB announces 2014 SRC: Protein Interactions, Structures, Technologies & Networks
9. FASEB announces 2014 Science Research Conference: Biology & Pathobiology of Krueppel-Like Factors
10. FASEB announces BioArt image and video competition winners
11. MARC travel awards announced for the July 2013 FASEB Science Research Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... 20, 2017 Delta (NYSE: DAL ) customers now ... aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at ... Delta,s biometric boarding pass experience ... is now integrated into the boarding process to allow eligible Delta SkyMiles ...
(Date:6/14/2017)...  IBM (NYSE: IBM ) is introducing several innovative ... to developing collaboration between startups and global businesses, taking place ... the event, nine startups will showcase the solutions they have ... France is one ... a 30 percent increase in the number of startups created ...
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder ... local San Diego Rotary Club. The event entitled “Stem Cells and ... had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: ...
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
Breaking Biology Technology: